PDDI Min Info Model Task Force - please complete a short questionnaire on how to represent PDDI importance

Dear Colleagues,

The draft Community Group Note for the Minimum Information Model for 
Potential Drug-drug Interaction (PDDI) Information currently 
distinguishes the seriousness of a PDDI from its severity. However, this 
might not be the best approach.

We have created a short and simple survey is intended to elicit your 
anonymous feedback on five potential alternatives to communicating the 
importance of a PDDI to clinicians. Would you please consider completing 
the survey by September 20th?

*Link the survey:*
https://pitt.co1.qualtrics.com/jfe/form/SV_e3rG1HYMzCDMLVX


Please feel free to distribute to your colleagues and relevant listservs.

We will compile all responses (anonymous) and use them to inform a new  
proposal for this topic for inclusion in the final version of the Note.


thank you and kind regards,

-Rich



-- 
Richard D Boyce, PhD
Associate Professor of Biomedical Informatics and Clinical and 
Translational Science in the Clinical and Translational
Science Institute
Director of the Informatics Core for the Center of Excellence for 
Natural Product- Drug Interaction Research (NaPDI)
Faculty, Center for Pharmaceutical Policy and Prescribing
Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research 
and Training Program
University of Pittsburgh
rdb20@pitt.edu
Office: 412-648-9219
Twitter: @bhaapgh